Monsanto’s (MON) Buy Rating Reiterated at Deutsche Bank AG
A number of other equities research analysts have also recently issued reports on MON. Zacks Investment Research upgraded shares of Monsanto from a sell rating to a hold rating in a report on Wednesday, June 8th. Piper Jaffray Cos. restated an overweight rating and set a $127.00 price target (up from $95.00) on shares of Monsanto in a report on Monday, June 13th. Argus restated a buy rating and set a $128.00 price target (up from $111.00) on shares of Monsanto in a report on Wednesday, June 15th. Goldman Sachs Group Inc. set a $92.00 price target on shares of Monsanto and gave the company a sell rating in a report on Monday, June 27th. Finally, Vetr upgraded shares of Monsanto from a buy rating to a strong-buy rating and set a $116.55 price target for the company in a report on Monday, June 27th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $114.65.
Monsanto (NYSE:MON) opened at 102.97 on Thursday. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26. The firm has a market capitalization of $45.07 billion, a P/E ratio of 34.46 and a beta of 1.19. The firm has a 50-day moving average price of $104.83 and a 200-day moving average price of $101.68.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the prior year, the company posted ($0.19) earnings per share. Monsanto’s revenue for the quarter was up 8.8% on a year-over-year basis. Equities analysts forecast that Monsanto will post $4.89 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be issued a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.10%. Monsanto’s dividend payout ratio (DPR) is presently 71.05%.
In related news, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by company insiders.
Several large investors have recently modified their holdings of MON. WFG Advisors LP raised its stake in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock worth $104,000 after buying an additional 158 shares during the last quarter. Howard Hughes Medical Institute bought a new stake in shares of Monsanto during the first quarter worth approximately $110,000. Signaturefd LLC raised its stake in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock worth $112,000 after buying an additional 415 shares during the last quarter. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares during the last quarter. Finally, Pinkerton Retirement Specialists LLC raised its stake in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock worth $114,000 after buying an additional 1,014 shares during the last quarter. Institutional investors and hedge funds own 79.02% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.